MedTrace Logo

Evaluating Risk Factors and Biomarkers for Adaptation and Resilience to Spaceflight

NCT03786016 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-04-06

No results posted yet for this study

Summary

This study assesses differences in biological and behavioral domains that relate to individual adaptation and resiliency to an isolated, confined and controlled environment, and evaluates the effect of confinement, work, monotony, and social and physical isolation on stress resiliency and well-being.

Conditions

  • Resilience
  • Mood
  • Performance
  • Stress, Psychological

Interventions

BEHAVIORAL

8-Days in an Isolation, Confinement Unit

Subjects will spend 8 days/7 nights continuously in an isolated and confined unit with up to 3 other subjects. Subjects will participate in daily, timed activities such as space-relevant computer simulations, team tasks, and cognitive performance testing. Subjects will also experience altered environmental conditions (such as changes in lighting, sound and ambient temperature) while in the isolation unit. Subjects will receive orders from "mission control" who will monitor activity in the isolation unit and direct subjects throughout the 8-day study.

Sponsors & Collaborators

  • University of Pittsburgh

    collaborator OTHER

  • National Aeronautics and Space Administration (NASA)

    collaborator FED

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • David Dinges, PhD · University of Pennsylvania

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-22
Primary Completion
2024-12-10
Completion
2025-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786016 on ClinicalTrials.gov